News

Being HIV positive and staying on antiretroviral therapy in Africa

An international team of researchers have carried out a review of the evidence examining what influences people who are HIV positive to go to health services and then stay on antiretroviral drugs in Africa.

advertisement

In a paper published in the Journal PLOS One the team, led by LSTM s Professor Paul Garner, used advanced methods of thematic synthesis to examine over 59 studies carried out in Africa, extracting key messages from the qualitative research. Professor Garner said: "We wanted to bring together the mass of research exploring what influences people taking and continuing to take antiretroviral drugs. Much has been achieved by governments, donors, NGOs and the World Health Organization in ensuring that people have access to these life-saving treatments but our review offers -- for the first time -- a more comprehensive understanding of the influences to treatment seeking and adherence to help health workers design approaches to keep people on their meds."

Dr Ingrid Eshun-Wilson, lead author on the paper, who carried out the work whilst based at the Centre of Evidence-Based Healthcare, Stellenbosch University said: "The mix of all these factors happen over time, so there appears to be a tipping point when patients choose to either engage or disengage from care, with HIV-positive patients potentially cycling in and out of these care states in response to fluctuations in influences over time."

The team hope that their work can contribute to the design of service delivery approaches, and informed thinking and action on the part of policy makers, providers, and society to understand what it is to be HIV-positive in Africa and how attitudes and the health service need to shift to help those with HIV lead normal lives.

"Our review goes beyond presenting barriers and facilitators such as cost and distance from care, which are well known." Continued Dr Eshun-Wilson: "We describe broadly how external influences and personal motivation interact and drive ART adherence and engagement decisions and presents a model for understanding why people do what they do."

advertisement

Materials provided by . Note: Content may be edited for style and length.

Liverpool School of Tropical Medicine. "Being HIV positive and staying on antiretroviral therapy in Africa." ScienceDaily. ScienceDaily, 11 January 2019. .

Liverpool School of Tropical Medicine. "Being HIV positive and staying on antiretroviral therapy in Africa." ScienceDaily. www.sciencedaily.com/releases/2019/01/190111095119.htm (accessed January 11, 2019).
Read more on sciencedaily.com
News Topics :
RELATED STORIES :
Science
New HIV infections in southern Africa could be reduced substantially by offering entire communities voluntary HIV testing, and immediately referring those who test positive for HIV treatment in line with...
Science
Coinfection with visceral leishmaniasis VL and human immunodeficiency virus HIV has been observed in at least 35 countries on four continents and requires special case management. Currently, the World Health...
Science
Eighty six percent of individuals who entered HIV care soon after diagnosis maintained viral suppression after 48 weeks during a clinical trial conducted at four National Institutes of Health NIH funded Centers...
Science
The HIV pandemic is not on track to end by 2030 and current approaches to HIV control are not enough to control it, according to a new Lancet Commission led...
Science
Many countries in sub Saharan Africa are facing an unprecedented epidemic of both infectious and non communicable diseases. This double burden of disease represents a major strain on already under resourced...